AVI Biopharma (AVII) Chief Scientific Officer to Resign
Tweet
Share
E-mailGet Alerts AVII Hot Sheet
Join SI Premium – FREE
In a Form 8-K filing, AVI Biopharma (Nasdaq: AVII) disclosed its Senior VP and Chief Scientific Officer Peter Linsley announced his resignation effective June 1st.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- AEye grants 125,000 RSUs to new chief revenue officer
- Balfour Beatty names Sarah Brand VP of Tampa buildings ops
Create E-mail Alert Related Categories
Hot M&A, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
